ArticleApplied biochemistry and biotechnology2025
Green Synthesis of Copper Oxide Nanoparticles using Dolichandrone falcata (Wall.ex DC.) Seem. Leaf Extract and Assessment of Antioxidant, Antimicrobial, Anti-diabetic and Anticancer Potentials.
Article in Applied biochemistry and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Phyto-synthesis of Copper Oxide Nanoparticles (CuO NPs) was carried out using Dolichandrone falcata leaves. The NPs were characterised using Ultraviolet-Visible spectroscopy (UV), UV-Vis diffuse reflectance spectroscopy (UV-DRS), X-ray diffraction analysis (XRD), scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FT-IR) and dynamic light scattering (DLS). The synthesised CuO NPs UV-Vis spectra revealed that a high absorption peak at 380 nm with optical band gap was 2.8 eV. The appearance of distinctive peaks in XRD pattern verified that CuO NPs were crystalline. Particle size distribution (DLS) revealed the average particle size 222 nm with Polydispersity Index (PDI) value is 0.348. The antibacterial ability of the synthesized CuO NPs was then investigated against major pathogens, including Gram-negative bacteria (Klebsiella pneumoniae and Pseudomonas aeruginosa) and Gram-positive bacteria (Staphylococcus aureus and Bacillus subtilis). Antioxidant activity against DPPH 61.10% ± 0.90 IC
Indexed as
Identifiers
40788618What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.